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Abstract

Ravilla, Nagendra Babu. M.S. Department of Pharmacology and Toxicology, Wright
State University, 2013.K-Cl cotransport: Role of KCC3 in cellular potassium (K)
homeostasis in KCC3-transfected HEK-293 cells.

K-Cl cotransport (KCC) mediated by four protein isoforms, KCC1 to KCC4, plays a
significant role in cell volume regulation, and in K and Cl homeostasis. In this study, we
demonstrate the importance of KCC3 and its two threonine (T) phosphorylation sites
T991 and T1048 in cellular K homeostasis in isogenic human embryonic kidney (HEK293) cells transfected with KCC3 wild type (WT) or constitutively active double mutant
KCC3 (AA) expressed under tetracycline or doxycycline control. In both WT and AA
cells, under baseline conditions, the Na-K-2Cl cotransport (NKCC) (55 %- 60 %) was the
major contributor of Rb influx followed by the Na/K pump (NKP) (35 % - 40 %) and
KCC (10 % - 15 %) even though the absolute values of Rb influx were higher in AA
cells. Doxycycline induction had no effect on either NKCC or KCC in WT cells, whereas
NKCC was completely inhibited and KCC was increased by 25 fold in AA cells. In AA
cells, intracellular K (Ki) decreased by 90 % upon doxycycline induction in Cl medium
and 50 % of this loss was attenuated in Cl-free (sulfamate replacement) medium.
Doxycycline-induced Cl-dependent Ki loss was sensitive to furosemide (2 mM) but
insensitive to tetra ethyl ammonium (TEA) (2 mM) and to changes in external K and Na,
whereas doxycycline-induced Cl-independent Ki loss was sensitive to 4-(2-butyl-6,7dichloro-2-cyclopentylindan-1-on-5-yl)oxybutyric acid (DCPIB) (50 µM) but insensitive
to TEA (2 mM), furosemide (2 mM) and extracellular K and Na.
iii

Table of Contents
1.

2.

3.

Introduction ............................................................................................................ 1
1.1.

K-Cl cotransport (KCC) .................................................................................. 2

1.2.

Significance of KCC ....................................................................................... 3

1.3.

Mechanisms regulating KCC .......................................................................... 6

1.4.

KCC3 structure................................................................................................ 9

Hypothesis and Specific Aims .............................................................................. 11
2.1.

Background for hypothesis ........................................................................... 11

2.2.

Hypothesis ..................................................................................................... 11

2.2.1.

Specific aim 1 ........................................................................................ 12

2.2.2.

Specific aim 2 ........................................................................................ 12

2.2.3.

Specific aim 3 ........................................................................................ 12

Materials and Methods ......................................................................................... 13
3.1.

Chemicals ...................................................................................................... 13

3.2.

Inhibitors ....................................................................................................... 13

3.3.

Solutions for flux studies............................................................................... 14

3.4.

KCC3 transfections ....................................................................................... 15

3.5.

Cell cultures................................................................................................... 15

3.6.

Ion flux studies .............................................................................................. 15

iv

4.

Results .................................................................................................................. 17
4.1.

Baseline Rb (K) influx components in KCC3 WT and AA cells.................. 17

4.2.

Doxycycline-induced Rb (K) influx in WT and AA cells ............................ 18

4.3.

Doxycycline-induced Rb (K) influx as a function of time ............................ 18

4.4.

Physiological factors affecting Rb influx in WT and AA cells..................... 21

4.5.

Intracellular K (Ki) in WT and AA cells ....................................................... 23

4.6.

Effect of extracellular K (Ko) on Ki loss in Na medium ............................... 27

4.7.

Effect of K o on K i loss in Na-free medium ......................................... 28

4.8.

Effect of furosemide on Cl-dependent Ki loss .............................................. 29

4.9.

Effect of TEA on Ki loss ............................................................................... 30

4.10.

Effect of DCPIB on Ki loss ....................................................................... 31

5.

Discussion ............................................................................................................. 33

6.

Acknowledgements .............................................................................................. 36

7.

References ............................................................................................................ 37

v

List of Figures

Figure Description

Page Number

Figure 1. Model for cell volume regulation ......................................................................... 7
Figure 2. Proposed KCC regulation mechanism by vasodilators in vascular smooth
muscle cells(VSCMs) .......................................................................................................... 8
Figure 3. Proposed mechanism of KCC regulation by platelet-derived growth factor
(PDGF) in VSMCs ............................................................................................................... 9
Figure 4. Hypothetical model of KCC3 structure ............................................................. 10
Figure 5. Baseline Rb (K) influx components and transporters for WT and AA cells ...... 17
Figure 6. NKCC and KCC in WT and AA cells before and after doxycycline induction. 19
Figure 7. Rb uptake as function of time in WT and AA cells ........................................... 20
Figure 8. Rb influx in Na and Na-free (NMDG) medium in WT and AA cells ................ 22
Figure 9. Effect of serum deprivation on NKCC and KCC in WT and AA cells ............. 22
Figure 10. Effect of tonicity on NKCC and KCC in WT and AA cells ............................ 23
Figure 11. Intracellular K content (Ki) in WT and AA cells for control and doxycyclineinduced cells....................................................................................................................... 24
Figure 12. Time-course of Ki content in WT and AA cells ............................................... 24
Figure 13. Hypothetical model for doxycycline-induced K loss in KCC3 (AA) mutant
cells .................................................................................................................................... 26
Figure 14. Approaches to inhibit Ki loss............................................................................ 27
Figure.15. Effect of extracellular K(Ko) on Ki in Na medium ........................................... 28
vi

Figure.16. Effect of Ko on Ki in Na-free medium .............................................................. 29
Figure.17. Effect of 2 mM furosemide on Ki loss (K) and Rb influx (Rb)........................ 30
Figure 18. Effect of TEA on Ki loss (K) and Rb influx (Rb) ............................................ 31
Figure 19. Effect of DCPIB on Ki loss (K) and Rb influx (Rb) ........................................ 32

vii

List of Tables
Table.1. K-Cl cotransport: Gene expression and significance ............................................ 5

viii

1.

Introduction
Regulation of cell volume is vital for cell survival. Lacking a rigid cell wall,

animal cells are more vulnerable to changes in extracellular or intracellular osmolality;
except in a few cell types, the cell membrane is highly permeable to water. However,
compared to the water permeability, the cell membrane’s permeability to Na+, K+ and Clis orders of magnitude lower. Thus to maintain a stable cell volume, both prokaryotic and
eukaryotic cells have evolved with numerous transporter proteins that transport Na+, K+
and Cl- across the plasma membrane. Regulation of these transporters is a highly
complicated physiological phenomenon involving several physical, chemical and
biological factors that act harmoniously with the ultimate aim to preserve membrane
integrity and cell volume.
According to the “pump and leak” hypothesis [8], cell swelling and lysis are
avoided by a limited permeability of the plasma membrane to Na, and by a continuous
Na-K-ATPase activity, which pumps Na out and K in. Most cells effectively counteract
changes in cell volume following perturbation in intracellular or extracellular osmolality
either by regulatory volume increase (RVI) or regulatory volume decrease (RVD) in
which several transporters and channels are involved [14, 48].
In osmotically swollen cells, K, Cl and other nonessential organic osmolytes exit
the cell followed by water, and this leads to the recovery of cell volume. This mechanism
is called RVD, which involves volume-sensitive Cl and K channels along with electroneutral KCC. In contrast, when a cell shrinks due to osmotic shock, Cl, K and Na enter
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the cell followed by water and thus restore the cell volume. This mechanism is defined as
RVI, which involves the Na/H exchanger, NKCC, and non-selective cation channels [14].

In this study, we explore the role of KCC in K and Cl homeostasis and cell
volume regulation in a human epithelial cell line by using KCC3 wild type (WT) and
KCC3 mutant (AA) transfected human embryonic kidney (HEK-293) cells. Before
providing a more detailed description of the study, a brief introduction about K-Cl
cotransport and its regulation and significance will be presented.
1.1.

K-Cl cotransport (KCC)
KCC is a secondary active transport that extrudes K and Cl out of the cell,

preserving intracellular Cl and K homeostasis and thus cell volume. This transport system
was first identified as an N-ethylmaleimide (NEM) - and swelling activated K efflux in
low K sheep red blood cells [42, 44]. It is encoded by four genes SLC12A4 to 7 and thus
has four protein isoforms KCC1 to KCC4 with splice variants in each isoform. KCC1,
being present in all the tissues, is considered as housekeeping KCC isoform [5, 38],
whereas KCC2 is mainly restricted to the central nervous system [18, 38], even though
recent studies confirmed its presence in lens epithelial cells [43], retinal neurons [20, 38]
and cervical cancer cells [59]. More recently, a second spliced variant of KCC2 has been
reported [52]. Therefore, the originally published KCC2 of the then neuronal system is
now the KCC2b variant, whereas the second and longer variant KCC2a occurs not only in
the brain but also in other tissues [47, 52]. KCC3 presence was reported for brain, heart,
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skeletal muscle and kidney [7, 25, 38]. KCC3 has NH2 – terminal heterogeneity with two
major isoforms, a longer KCC3a, and shorter KCC3b, which are highly expressed in
kidney (1). The KCC4 protein was discovered in several tissues like bone marrow, spleen,
thymus, spinal cord, brain, prostrate, pancreas, liver, skeletal muscle, heart lung and the
basolateral membranes of the nephron [7, 38]. The main function of these transporters is
regulation of cell volume by RVD [48]. When the extracellular milieu becomes
hypoosmotic, water enters the cell resulting in increased cell volume. This increased cell
volume activates the volume-sensitive K and Cl channels along with KCCs and extrudes
the K and Cl ions followed by water to bring the cell back to its original volume [48].
1.2.

Significance of KCC
Besides regulating the cellular volume, KCC has been implicated in several

pathologies and in cell growth and migration. Several reviews give us a clear idea about
the importance of KCC in sickle cell disease, cardiovascular pathology, epileptic seizures
and tumor biology [39, 10, 11, 21, 57]. Numerous studies have shown the importance of
KCC1 in cellular dehydration of red blood cells (RBCs) in homozygous sickle cell
disease [45, ref. in].
KCC2 being neuron specific has been reported to play an important role in
deciding the neurotransmitters GABAA and glycine function. During early fetal life,
GABAA and glycine act as excitatory neurotransmitters due to high intracellular Cl (Cli)
whereas in adult neuron, expression of KCC2 results in decreased Cli and this leads to
inhibitory action of GABAA and glycine [3, 6, 10]. KCC2 knockout mice cannot live and
die of respiratory failure [19]. Heterozygous mice with reduced KCC2 expression are
susceptible to hyper-excitability and epileptic seizures demonstrating the role of KCC2 in
epilepsy [41].
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Mutations in KCC3 are involved in an autosomal recessive syndrome called
Anderman syndrome in which agenesis (A) of carpus (C) callosum (C) is accompanied by
a peripheral (P) neuropathy (N) (ACCPN) [17], which is mostly seen in the FrenchCanadian population of the Quebec region of Canada. People with this disorder suffer
from areflexia, hypotonia, amyotrophy and tremors due to improper development of
certain cranial nerves. KCC3 knockout mice exhibit arterial hypertension [30, 40]. KCC3
knock out in mice also results in progressive neurodegeneration, deafness and decreased
threshold for seizure or epilepsy [55]. A study in KCC3-transfected NIH/3T3 fibroblasts
shows the role of this transporter in cell growth and proliferation [34]. Recent studies also
exploit the role of KCC, and specifically KCC3 and KCC4, in cancer cell invasion and
proliferation [58, 560, 59]. Besides its role in tumor biology, KCC4 is also important in
acid-base balance because mutations in KCC4 result in renal tubular acidosis [54].
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Table 1. K-Cl cotransport: Gene expression and significance (Modified from ref.21)

Gene
Human
Gene Locus
Protein
Isoforms
and Amino
Acid
Residues
Tissue
Expression

SLC12A4
16q22

SLC12A5
20q13

SLC12A6
15q14

SLC12A7
5p15

KCC1
1085

KCC2
KCC2a-1075
KCC2b-1115

KCC3
KCC3a-1150
KCC3b-1099

KCC4
1083

Ubiquitous

Neurons and
other tissues

Extensive

Direct
Disease
Association
KO
Phenotype

-

-

No
phenotype

Importance
in Complex
Disease

Sickle cell
anemia?

Death by
respiratory
failure,
incomplete
knock-outepilepsy,
death in 15
days
Epilepsy

ACCPN
(Anderman
Syndrome)
Hypertension,
deafness,
tumor biology

Extensive;
Limited in
Brain
-
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Renal tubular
acidosis,
epilepsy,
sickle cell
anemia

Renal tubular
acidosis,
epilepsy,
sickle cell
anemia

Renal tubular
acidosis,
epilepsy, sickle
cell anemia

1.3.

Mechanisms regulating KCC
The role of numerous signaling pathways in regulating KCC activity has been

elucidated. Phosphorylation/dephosphorylation of the transporter through series of
kinases/phosphatases is the major mechanism that regulates this transporter as initially
proposed by Jennings [33]. Phosphorylation inhibits KCC and activates NKCC and vice
versa via dephosphorylation. Studies during the last decade have elucidated the essential
role of “with no lysine kinases” (WNKs) in the regulation of NKCC and KCC (26, 27, 28,
29). NKCC regulation by WNK kinases via Ste20/Sps1-related proline/alanine rich
kinase (SPAK) and the oxidative stress responsive kinase 1(OSR1) has been well
explored compared to KCC regulation through these kinases (24, 11). Regulation of
NKCC and KCC via these kinases and their role in cell volume regulation is shown in
figure 1. Other major mechanisms include the regulation by the NO/cGMP/PKG pathway
[31, 38] and PDGF-mediated pathway in vascular smooth muscle cells (VSMCs) [32, 36,
38 and ref. in] and the phosphoinositol/PKC pathway in low-K sheep red cells which
have KCC1 and KCC3 isoforms [4, 38].

6

Figure 1. Model for cell volume regulation. Role of osmosensitive kinases
and phosphatases and of NKCC, and KCC in cell volume regulation via RVI
and RVD. Details are discussed in text.
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Figure 2. Proposed KCC regulation mechanism by vasodilators in vascular smooth
muscle cells. Vasodilators (VDs) such as sodium nitroprusside (SNP) release nitric oxide
(NO) and activate the soluble guanylyl cyclase (sGC). The enzyme converts GTP into
cGMP and this, in turn, activates protein kinase G (PKG) which, by an unknown
mechanism, activates protein phosphatase 1 (PP1) and KCC. SNP and 8-Br cGMP, NO
donor and PKG activator, respectively, stimulate the KCC, whereas sGC and PKG
antagonists LY 83583 and KT 5823, respectively, inhibit KCC. (Redrawn from [36])
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Figure 3. Proposed mechanism of KCC regulation by platelet-derived growth factor
(PDGF) in VSMCs. PDGF binds to its receptor and activates PI 3-K which, through an
unknown mechanism, activates PP1, leading to dephosphorylation and activation of K-Cl
COT. Involvement of the PDGF receptor was uncovered by inhibition with AG1296.
Participation of PI 3-K was determined by inhibition with Wortmannin and LY294002.
Finally, participation of PP1 was studied with calyculin A, a selective inhibitor of the
phosphatase. (Redrawn from [36]).

1.4.

KCC3 structure
As represented in figure.2, human KCC3 is a trans-membrane protein with

KCC3a and KCC3b isoforms constituting 1150 and 1099 amino acid residues,
respectively, with molecular weights of the un-glycosylated proteins of 130 and 125 kDa,
respectively, possessing an intracellular short N-terminal and long C-terminal, and an
extracellular loop connecting trans-membrane domains 5 and 6. KCC3 bears several
glycosylation sites on its extracellular loop whose functions are still unknown. Recent
9

studies revealed that KCC3 has two functionally significant phosphorylation sites;
threonine (T) 991 and 1048; their deletion or mutation perturb KCC activity [22].

Figure 4. Hypothetical model of KCC3 structure. KCC3 is reported to contain 12transmembrane domains, a larger extracellular loop between domains 5 and 6, and
intracellular N- and C-terminal domains, in addition to phosphorylation and glycosylation
sites. Details are discussed in the text.
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2.

Hypothesis and Specific Aims

2.1.

Background for hypothesis
The two functionally important threonine (T) kinase phosphorylation sites in

KCC3, T991 and T1048, are localized on its C-terminal. The double A substitution
prevents phosphorylation, which inhibits KCC3 at these sites, and hence activates the
transporter. Thus, the AA mutant mimics the dephosphorylated KCC3 that is present
during RVD [22]. We detected permanent activation of KCC3 through increased Rb (K)
influx. Preliminary data from our experiments showed that increased Rb (K) influx was
associated with K loss in KCC3AA-transfected HEK-293 (AA) cells. Based on these
data, we propose the following hypothesis.
2.2.

Hypothesis
The threonine (T) phosphorylation sites T991 and T1048 on KCC3 are important

for K-Cl cotransport regulation. Their replacement with alanine (A) permanently activates
KCC3 as measured by Cl-dependent Rb influx and K-loss. Expression in HEK-293 cells
of the AA-mutant KCC3 also may result in collateral stimulation of K loss mechanisms
and perturb cellular K homeostasis.
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2.2.1. Specific Aim 1
Characterize baseline and doxycycline-induced Rb (K) influx under physiological
conditions in the presence and absence of Cl anions, and thus K-Cl cotransport, in WT
and AA transfected HEK293 cells to determine whether AA cells are indeed permanently
activated.
2.2.2. Specific Aim 2
Determine whether AA cells are indeed permanently activated by assessing the role of
confounding factors such as external Na, serum deprivation and osmolality on Rb influx.
2.2.3. Specific Aim 3
Identify K loss mechanisms induced by doxycycline in AA cells utilizing ion substitution
and a variety of chemical inhibitors of K, Cl and Ca channels.
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3.

Materials and Methods

3.1.

Chemicals
Chemicals from Fisher Scientific (Fair lawn, NJ) were: Tri-hydroxyamino

methane (Tris) free base, sodium chloride (NaCl), potassium chloride (KCl), magnesium
chloride (MgCl2), sodium hydroxide (NaOH), sucrose, D-glucose, perchloric Acid, 70 %
(PCA), and bicinchonic acid (BCA) protein assay reagents. Magnesium gluconate was
from Sigma-Aldrich (St. Louis, MO). (4-(2-hydroxyethyl)-1-piperazine ethane sulfonic
acid (HEPES) free acid, and calcium chloride (CaCl2), anhydrous were from J.T.Baker
Chemical Co (Center valley, PA). Rubidium chloride (RbCl), 99.8 % (metals basis), and
amidosulfonic acid (sulfamic acid, S), 99.99 % (metals basis) were purchased from Alfa
Aesar (Ward Hill, MA); N-methyl D-glucamine (NMDG) from Fluka Biochemika (St.
Louis, MO); Cesium chloride (CsCl) from Life technologies (Carlsbad, CA) and calcium
gluconate from Acros Organics (NJ).
3.2.

Inhibitors
Ouabain octahydrate was purchased from Calbiochem (San Diego, CA),

furosemide and bumetanide from Sigma-Aldrich (St. Louis, MO), DCPIB from Tocris
Bioscience (Bristol, UK), tetra ethyl ammonium (TEA) from Abcam (Cambridge, MA),
clofilium tosylate from Enzo life sciences (Farmingdale, NY), and RN-1734 and
Ruthenium Red from Santa Cruz Biotechnology (Santa Cruz, CA).
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3.3.

Solutions for flux studies

Washing solutions
Balanced salt solution (BSS-NaCl): 20 mM Hepes-Tris, 5 mM KCl, 2 mM CaCl2, 1mM
MgCl2, 10 mM glucose and NaCl, pH 7.4, 37 0C, 300 mOsM.
BSS-NaS: 20 mM Hepes-Tris, 5mM K sulfamate, 2 mM Ca gluconate, 1 mM Mg
gluconate, 10 mM glucose and NaS. pH 7.4, 37 0C, 300 mOsM.
Pre-incubation solutions
BSS-NaCl-BSA: 20 mM Hepes-Tris, 5 mM KCl, 2 mM CaCl2, 1 mM MgCl2, 10 mM
glucose, 0.1 % BSA and NaCl, pH 7.4, 37 0C, 300 mOsM.
BSS-NaS-BSA: 20 mM Hepes-Tris, 5 mM K sulfamate, 2 mM Ca gluconate, 1 mM Mg
gluconate, 10 mM glucose, 0.1 % BSA and NaS. pH 7.4, 37 0C, 300 mOsM.
Flux solutions
BSS-RbCl-NaCl-BSA: 20 mM Hepes-Tris, 10 mM RbCl, 2 mM CaCl2, 1 mM MgCl2, 10
mM glucose, 0.1 % BSA and NaCl, pH 7.4, 37 0C, 300 mOsM.
BSS-RbS-NaS-BSA: 20 mM Hepes-Tris, 10 mM Rb sulfamate, 2 mM Ca gluconate, 1
mM Mg gluconate, 10 mM glucose, 0.1 % BSA and NaS. pH 7.4, 37 0C, 300 mOsM.
Final wash solution
10 mM MOPS-Tris, MgCl2, pH 7.4, 37 0C, 300 mOsM.
Rb Extraction
5 % perchloric acid, 4 mM CsCl
Protein dissolution
1M NaOH
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3.4.

KCC3 transfections
Single copies of WT or AA human KCC3a cDNAs with an N-terminal myc

epitope stably expressed under control of tetracycline were transfected into HEK-293
cells using Flip-in T-Rex System (Invitrogen). In this study, doxycycline, a tetracycline
derivative, was used to induce gene expression.

3.5.

Cell cultures
Human embryonic kidney (HEK293) cells stably transfected with WT or AA

KCC3a cDNAs were cultured in Dulbecco's Modified Eagle (DMEM) high glucose
medium (Life Technologies, Catalog No.11965-092) supplemented with 10 %
tetracycline-free fetal bovine serum (FBS) (Clontech, Catalog No.631106), 100 units/ml
penicillin (Hyclone, Catalog No. SV30010), 100 µg/ml streptomycin (Hyclone, Catalog
No. SV30010) and 10 µg/ml blasticidin S hydrochloride (Santa Cruz, Catalog No. sc204655) in a humidified incubator with 5 % CO2 at 37 0C.

3.6.

Ion Flux Studies
Ion fluxes were determined according to previously published protocols (23, 35,

37) with some modifications. Cells were grown to 60 % confluence in 12-well plates;
KCC3 was expressed by overnight doxycycline (1µg/ml) induction. WT- or AA-treated
cells were removed from the incubator, culture medium was aspirated, washed three times
with 1ml 300 mOsM BSS-NaCl or BSS-NaS and then equilibrated in BSS-BSA-NaCl or
BSS-BSA-NaS, pH 7.4, 37 0C for 10 min, thereafter supernatants were removed and then
exposed to pre-warmed actual flux media BSS-BSA-RbCl or BSS-BSA-RbS for predetermined time points (2.5 min to 15 min). Thereafter, cells were washed with washing
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solution at room temperature to block Rb influx or Ki loss, cellular Rb and K were
extracted after cell lysis by exposing for 15 min to ice cold 5 % PCA and finally protein
was extracted by dissolving in 1 M NaOH. Rb and K were measured by atomic emission
and absorption spectrophotometry, respectively using a Perkin Elmer 5000 atomic
absorption spectrophotometer. Protein was determined by the BCA assay. Rb uptake or
Ki loss was calculated in nmoles/mg protein as function of time. Ouabain (0.1 mM) and
bumetanide (10 µM) were added to the flux media to block NKP and NKCC,
respectively. Ouabain- and bumetanide-sensitive Rb influx in Cl was calculated as NKP
and NKCC, respectively, whereas Cl-dependent Rb influx in presence of ouabain and
bumetanide was determined as KCC.
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4.

Results

4.1.

Baseline Rb (K) influx components in KCC3 WT and AA cells

Figure 5. Baseline Rb (K) influx components and transporters for WT and AA cells.
Flux time was 5 min and Rb influx components and transporters were calculated as
described in Materials and Methods. n = 9 for WT cells, and n = 6 for AA cells; values
are means ± S.E. Details are discussed in the text.
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Baseline NKP, NKCC and KCC were calculated by performing unidirectional
uptake experiments using Rb as K congener in KCC3 WT- and AA-transfected HEK-293
cells. The transporter activities were calculated as the Rb influx in (nmoles/mg protein) as
shown in [Fig.5]. In WT cells, NKP and NKCC contributed to 90 % of the total Rb influx
whereas only 10 % of influx occurred through KCC. The major contributor of the Rb
influx was NKCC (50 %) followed by NKP (40 %). In AA cells, baseline NKCC activity
was 58-60 % of the total Rb influx followed by NKP (28-30 %) and KCC (10-12 %),
which are basically similar to the values observed in WT cells. Furthermore, under
baseline conditions NKCC was the major component of Rb (K) influx in both WT and
AA cells and was slightly more active in AA cells, whereas KCC activity was quite
similar in both types of cells.
4.2.

Doxycycline-induced Rb (K) influx in WT and AA cells
Rb influx was measured after overnight gene expression under doxycycline

control. NKCC and KCC were calculated and results are shown in [Fig.6]. Doxycycline
did not induce significant changes on NKCC and KCC activities in WT cells, whereas in
AA cells, it induced a 25 fold increase in KCC activity. RbCl uptake was larger in the
presence of ouabain and bumetanide compared to the uptake in the presence of ouabain
alone and thus it resulted in calculated negative NKCC values, which have no physical
meaning.
4.3.

Doxycycline-induced Rb (K) influx as function of time
The doxycycline-induced RbCl uptake was calculated as a function of time in WT

and AA cells and the results for 5 min flux are shown in [Fig.5]. Furthermore, in WT
cells, NKCC and NKP activities were non-linear even at the earliest time point tested (i.e.
2.5 min) whereas KCC activity was linear up to 15 min [Fig.7]. In AA cells, KCC activity
18

was non-linear and saturated at 10 min, whereas NKCC activity became more negative
with increasing time (negative values have no physical meaning as discussed earlier) that
could be due to an increase in Rb uptake in the presence of bumetanide.

Figure 6. NKCC and KCC in WT and AA cells before and after doxycycline
induction. NKCC and KCC were calculated as the Cl-dependent ouabain-insensitive,
bumetanide-sensitive and Cl-dependent (ouabain + bumetanide)-insensitive Rb influx
(nmoles/mg protein x 5 min), respectively. n = 9 for WT cells and n = 4 for AA cells.
Values are means ± S.E. Details are discussed in the text.
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Figure 7. Rb uptake as function of time in WT and AA cells. Rb transporters NKP,
NKCC and KCC were calculated as described in Materials and Methods. n = 9; values are
means ± S.E. Details are discussed in the text.
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4.4.

Physiological factors affecting Rb influx in WT and AA cells
To better understand the response of Rb (K) influx both in WT and AA mutants;

we tested the effect of physiological factors such as external Na, serum and osmolality in
these cells, [See Figs. 8, 9 and 10, respectively]. To assess the effect of external Na (Nao)
on Rb influx, N-methyl D-glucamine (NMDG) was used as Na replacement. As expected,
in both WT and AA cells the Na-dependent transporter NKCC was completely inhibited
in Na-free medium, whereas KCC was not affected in WT cells. Interestingly, in AA
cells, the doxycycline-induced KCC activity was reduced by 30 % in the absence of
external Na. Furthermore, serum deprivation for 24 h had no statistically significant
effect on KCC activity under baseline and doxycycline-induced conditions both in WT
and AA cells, in contrast to previous observations (36 and ref. therein), whereas NKCC
was inhibited by 25 % under baseline conditions and, as shown earlier, it was abolished
in doxycycline-induced cells. In general, hypertonicity activates NKCC and inhibits KCC
and hypotonicity inhibits NKCC and activates KCC. In WT cells, NKCC was activated
by both hypertonicity and hypotonicity and KCC was unaffected (Fig. 10WT). This result
could be outcome of variable ionic strength in flux media. In AA cells neither NKCC nor
KCC was affected by changes in osmolality (Fig.10AA). This result was expected
because permanently activated KCC3 is insensitive to changes in osmolality [22].
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Figure 8. Rb influx in Na and Na-free (NMDG) medium in WT and AA cells. NKCC
and KCC represent Rb influx in the absence of doxycycline, and DNKCC and DKCC
represent Rb influx after overnight doxycycline induction. n = 6; values are ± S.E. Details
are discussed in the text.

Figure 9. Effect of serum deprivation on NKCC and KCC in WT and AA cells.
NKCC and KCC are controls, DNKCC and DKCC in the presence of doxycycline. Flux
time, 5 min; n = 4 for WT cells and n = 6 for AA cells. Values are means ± S.E. Details
are discussed in the text.
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Figure 10. Effect of tonicity on NKCC and KCC in WT and AA cells. Doxycycline
induced NKCC and KCC activity in hypotonic (200 mOsM), isotonic (300 mOsM) and
hypertonic (450 mOsM) flux media with variable ionic strength. Flux time 5 min. n = 6;
values are means ± S.E. Details are discussed in the text.
4.5.

Intracellular K (K i ) in WT and AA cells
Figure.11. shows Ki in WT cells, when 15 min measured after exposure to Cl or S

media in the presence of ouabain and of [ouabain + bumetanide]. Note that in S, there was
a 30% Ki loss with respect to ClO or ClOB and was not affected by doxycycline
treatment. By definition, Ki loss in sulfamate indicates activation of a Cl-independent K
loss mechanism. Surprisingly, induction of KCC3 by doxycycline in AA cells caused a 75
% Ki loss in Cl, 50 % of which was recovered by placing the cells in S medium, as
shown in (Fig. 11 AA), indicating activation of a Cl-dependent Ki loss mechanisms
through the KCC. Furthermore, increase in flux time from 2.5 min to 10 min increased
the doxycycline-induced Cl-dependent K loss but no significant change was observed in
the Cl-independent Ki loss (Fig. 12 AA).
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Figure 11. Intracellular K content (Ki) in WT and AA cells for control and
doxycycline-induced cells. Ki after flux in 10 mM RbCl with 0.1 mM ouabain (ClO);
with 0.1 mM ouabain + 10 µM bumetanide (ClOB); –and 10 mM RbS with 0.1 mM
ouabain + 10 µM bumetanide (SOB). Flux time, 5 min; n = 9; values are means ± S.E.
Details are discussed in the text.

Figure 12. Time-course of Ki content in WT and AA cells in the absence and
presence of doxycycline (D). Ki after flux in 10 mM RbCl, with 0.1 mM ouabain (ClO);
with 0.1 mM ouabain + 10 µM bumetanide (ClOB); –and 10 mM RbS with 0.1 mM
ouabain + 10 µM bumetanide (SOB). Flux time, 5 min; n = 9; values are means ± S.E.
Details are discussed in the text.
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This doxycycline-induced unidentified and significantly large Ki loss in isotonic
conditions was not reported in any previous studies. So, we hypothesized that this Ki loss
in AA cells under isotonic conditions could be the result of an imbalance in intracellular
ion concentrations caused by the permanently activated KCC3AA.
According to our hypothesis, doxycycline induces a Cl-dependent Ki loss through
KCC matched by a significantly increased RbCl uptake caused by expression of the
KCC3 mutant in HEK-293 cells. Doxycycline may also activate a Na channel such as the
epithelial Na channel (ENaC) that transports Na into the cell, thus resulting in increased
intracellular Na, leading to depolarization and swelling and consequently opening
swelling-activated Cl (Clswell) and voltage-sensitive Ca channels, inducing Ca-activated
Ca release from intracellular stores, and opening K and Cl channels (Fig.13). To test this
hypothesis we have used ion replacement studies and several inhibitors of Cl, K and Ca
channels (Fig. 14). The results will be discussed in the following sections.
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Figure 13. Hypothetical model for doxycycline-induced K loss in KCC3 (AA) mutant
cells
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Figure 14. Approaches to inhibit K loss. The effectors/inhibitors in the diagram are:
NMDG (Na replacement), Furo, furosemide, a KCC and anion channel blocker, DCPIB, a
volume-sensitive Cl channel blocker, TEA/Clofilium, inhibitors of Ca-dependent and Caindependent channels, respectively, RR, Ruthenium Red, 1,2-Bis(2-aminophenoxy)
ethane-N,N,N′,N′-tetra acetic acid (BAPTA), ethylene diamine tetra acetic acid (EDTA),
Ca chelators, RN-1734, a selectiveTRPV4 channel blocker.

4.6.

Effect of extracellular K (Ko)on Ki loss in Na medium
According to the Nernst equation, under physiological conditions, even a small

rise in Ko leads to a more positive membrane potential and may result in depolarization.
So, decrease or complete removal of Ko may lead to hyperpolarization and maintenance
of Ki. To test this hypothesis, we have used 10 mM Rb, 5 mM K and 0 mM K/Rb flux
media maintaining other components constant and the results are plotted in (Fig. 15).
Results indicate inhibition of Cl-dependent Ki loss in 5 mM K and 0 mM K/Rb media but
no effect on Ki loss in 10 mM Rb. The possible explanation for this inhibition of Ki loss
in 5 mM K medium is bidirectional transport of K through KCC i.e. equal K influx and
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efflux that, given the existent gradients, results in unchanged Ki whereas KCC inhibition
by removal of extracellular K/Rb leads to inhibition of Cl-dependent Ki loss in 0 mM
K/Rb medium which is not consistent with the loaded form of the carrier being rate
limiting in sheep red cells [12].

Figure 15. Effect of extracellular K (Ko) on Ki in Na medium. Ki in Cl with no
inhibitors (Cl); ouabain (ClO); ouabain + bumetanide (ClOB); and in sulfamate (S) with
ouabain + bumetanide (SOB). Flux time, 5 min. n=12; values are means ± S.E. Details
are discussed in the text.

4.7.

Effect of extracellular K (K o ) on K i loss in Na-free medium
According to our hypothesis, doxycycline induces an increase in intracellular Na

by opening a Na channel, which may lead to depolarization and Ki loss. Replacing Nao
with NMDG may preclude the Na-induced depolarization and consequently, the Ki loss.
So, we have conducted experiments in NMDG under the same conditions described in the
former section, i.e. 0 mM K/Rb, 5 mM K and 10 mM Rb flux media. In contrast to
expectations, the results were essentially no different from those in Na medium,
indicating either no or a partial role of Nao on doxycycline-induced Ki loss (Fig.16).
Furthermore, inhibition of doxycycline-induced Cl-dependent Ki loss even in Na-free
media at 0 mM K/Rb and 5 mM K confirmed the role of KCC in this process.
28

Figure 16. Effect of extracellular K (Ko) on Ki in Na-free medium. Na was replaced
with NMDG. Ki in Cl, with no inhibitors (Cl); ouabain (ClO); ouabain + bumetanide
(ClOB); and sulfamate (S) with ouabain + bumetanide (SOB). Flux time, 5 min. n=6;
values are means ± S.E. Details are discussed in text.

4.8.

Effect of furosemide on Cl-dependent Ki loss
To further investigate the role of KCC in doxycycline-induced Ki loss, we have

used 2 mM furosemide, an inhibitor of both NKCC, and KCC [43]. Furosemide, when
used only during doxycycline induction had no effect on Ki loss but when used during
both preincubation and flux inhibited doxycycline- induced Cl-dependent K loss although
no effect was observed on Cl-independent Ki loss (Fig.17). As expected, furosemide also
reduced RbCl uptake through KCC to baseline levels. In conclusion, the ion replacement
studies and those with furosemide confirmed that doxycycline induced a Cl-dependent Ki
loss through KCC.
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Figure 17. Effect of 2 mM furosemide on Ki loss (K) and Rb influx (Rb). ClO and
ClOB refer to Ki after flux in Cl with ouabain, or ouabain + bumetanide, respectively.
SOB refers to Ki after flux in S with ouabain + bumetanide. D, doxycycline; furosemide;
P, preincubation; fl, flux. n = 9; values are means ± S.E. Details are discussed in the text.

4.9.

Effect of TEA on K i loss
TEA, a blocker of Ca-dependent K channels inhibits the big conductance K

channel (BK) at 2 mM and non-selectively other K channels at 10 mM. In addition, TEA
inhibited Ki loss in several studies (9, 15). To block the massive doxycycline-induced K
loss in AA cells, we used TEA at 2 mM during doxycycline induction alone, during
induction and preincubation, or during induction, preincubation and flux. No effect of
TEA at 2 mM was observed on Ki loss and Rb influx under any of the tested conditions
implying that the BK channel was not responsible for the large Ki loss from AA cells
(Fig.18).
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Figure 18. Effect of TEA on Ki loss (K) and Rb influx (Rb). ClO and ClOB refer to Ki
after flux in Cl with ouabain, or ouabain + bumetanide, respectively. SOB refers to Ki
after flux in S with ouabain + bumetanide. D, doxycycline; P, preincubation; fl, flux. n =
6; values are means ± S.E. Details discussed in the text.

4.10. Effect of DCPIB on K i loss
DCPIB, a volume-sensitive Cl channel blocker, is known to inhibit Ki loss
through IK channels in human lens epithelial cells [49]. DCPIB (50 µM) was used during
either flux alone, pre-incubation and flux, or doxycycline induction, preincubation and
flux. Complete inhibition of Ki loss was achieved in the latter condition where Ki was
maintained at the control level. However, DCPIB also inhibited KCC by 50% (Fig. 19)
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Figure 19. Effect of DCPIB on Ki loss (K) and Rb influx (Rb). ClO and ClOB refer to
Ki after flux in Cl with ouabain, or ouabain + bumetanide, respectively. SOB refers to Ki
after flux in S with ouabain + bumetanide. D, doxycycline; P, preincubation; fl, flux. n =
6; values are means ± S.E. Details are discussed in the text.
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5.

Discussion
A recent study by Rinehart et al. [22] revealed the functional importance of two

C-terminal threonine (T) phosphorylation sites; T991 and T1048 in KCC3 regulation. By
assessing the increased Rb influx, they demonstrated that replacement of these two amino
acids at 991 and 1048 with alanine leads to permanent activation of KCC3 under isotonic
conditions. In this study, we investigated the importance of KCC3 and its two
functionally important phosphorylation sites T991 and T1048 in Ki homeostasis, in a
human epithelial cell line.
By performing Rb influx studies and measuring Ki in WT- and AA-transfected
HEK-293 cells, we have investigated the perturbed cellular K homeostasis in AA cells. In
WT cells, neither KCC nor NKCC activity were affected by 16 h doxycycline induction
whereas in AA cells, KCC increased by 25 fold, which is consistent with previous
findings. NKCC was inhibited completely and negative (see Fig.6). This negative NKCC
in AA cells needs to be further explored.
In AA cells, doxycycline induction lead to a significant Ki loss (> 90 %) in Cl, and
50 % of this loss was recovered in Cl-free medium, an effect not seen in WT cells,
indicating that permanent activation of KCC3 altered K homeostasis. Partial inhibition of
Ki loss in sulfamate medium shows that it has two components, a Cl-dependent and an
unidentified Cl-independent Ki loss. The doxycycline-induced Cl-dependent K loss was
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inhibited by replacing extracellular Rb with K, and by 2 mM furosemide (Fig. 12, 13, 14).
This finding means that Ki loss occurred through KCC mediated K efflux.
Presence of numerous endogenous voltage-dependent Na, K, Ca and Cl channels,
which can generate significant inward or outward currents has been reported for HEK293 cells in several previous studies (2, 4, 31, 51, 53). So, we attempted to inhibit the
doxycycline-induced Cl-independent Ki loss by changing extracellular ion concentrations
by ion replacement studies and by various K, Ca and Cl channel inhibitors. Changes in
extracellular Na and K did not have any effect on the doxycycline-induced Clindependent Ki loss. The Ca-dependent K channel blocker TEA (2 mM), reported to
block the big conductance (BK) channels in several studies, failed to inhibit the Clindependent Ki loss, excluding the role of BK channels in AA Ki loss. Clofilium tosylate
(100 µM) another Ca-independent K channel blocker had no effect on Ki loss when used
either during doxycycline induction alone or in addition to pre-incubation and flux (data
not shown). Our experiments with Ca chelators such as EDTA, BAPTA and TRPV4
channel blockers like RN-1734 are inconclusive. DCPIB (50 µM) a volume-sensitive Cl
channel blocker when used during (doxycycline + pre-incubation + flux) completely
inhibited the Ki loss. However, partial inhibition of KCC by DCPIB prevented us from
concluding the role of volume-sensitive Cl channels in Ki loss.
In conclusion, expression of permanently activated KCC3 into HEK-293 cells
under doxycycline control results in altered intracellular ion concentrations leading to Ki
loss through Cl-dependent and Cl-independent pathways, indicating the importance of
KCC3 in cellular K homeostasis. In addition, the Cl-independent K loss is insensitive to
34

TEA (2 mM), furosemide (2 mM) and to changes in Ko and Nao concentrations but
sensitive to DCPIB (50 µM).
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